T2DM Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Question | Answer |
What are the 4 methods to diagnose T2DM? | 1. A1c >= 6.5% 2. OGTT with 75 g glucose >= 200 mg/dl 3. 8-hr FPG >= 126 mg/dl 4. Symptomatic with BG >= 200 mg/dl |
What is the definition of pre-diabetes? | 1. FPG 100-125 mg/dl 2. 2-hr OGTT 140-199 mg/dl 3. A1c 5.7-6.4% |
What are the physical activity recommendations for diabetic patients? | 150 minutes a week, spread over 3 days, without more than 2 consecutive days of inactivity |
What is the target weight loss in diabetic patients? | 7% of body weight |
What is the A1c goal for non-pregnant adults? What are alternate goals for healthy and non-healthy patients? | < 7.0%. 6.5% and 8.0% |
What are the glycemic recommendations for non-pregnant diabetic patients? | 1. Pre-prandial PG 80-130 mg/dl 2. Post-prandial PG < 180 mg/dl |
What is the recommended treatment for hypoglycemia? | 15-20 g glucose, repeated in 15 minutes if hypoglycemia is still present, followed by a snack |
What is the preferred first line treatment? | Metformin |
When should you consider initiation dual hypoglycemic treatment? | A1c >= 9% |
When should you consider initiating insulin? | A1c >= 10-12% |
Metformin: brand name | Glucophage |
Metformin: BBW | Lactic acidosis |
Metformin: dosing | 500mg bid with meals titrated to 1000mg bid after 1-2 weeks |
Metformin: dosing adjustments | GFR < 45 decrease dose to 500mg bid, GFR < 30 contraindicated |
Metformin: class | biguanide |
Metformin: MOA | Decreased hepatic glucose production, decreased intestinal absorption of glucose, improved insulin sensitivity |
Metformin: AEs (4) | diarrhea, nausea, vomiting, flatulence |
Glimepiride: brand name | Amaryl |
Glimepiride: dosing | 1-2mg daily with biggest meal titrated to max of 8mg daily |
Glimepiride: dosing adjustments | renal impairment start at 1mg daily and adjust carefully, use with caution in hepatic impairment |
Glimepiride: class | sulfonylurea |
Glimepiride: MOA | Stimulates insulin release from the pancreatic beta cells; reduces glucose output from the liver; insulin sensitivity is increased at peripheral target sites |
Glimepiride: AEs (2) | hypoglycemia, nausea |
Glipizide: brand name | glucotrol |
Glipizide: dosing | 2.5-5mg daily before breakfast titrated to a max of 40mg daily |
Glipizide: dosing adjustments | no renal adjustment, in hepatic impairment start with 2.5mg daily |
Glipizide: class | sulfonylurea |
Glipizide: MOA | Stimulates insulin release from the pancreatic beta cells; reduces glucose output from the liver; insulin sensitivity is increased at peripheral target sites |
Glipizide: AEs (3) | nauses, diarrhea, hypoglycemia |
Glyburide: brand name | Diabeta |
Glyburide: dosing | 1.5-3mg with first meal titrated to max of 12mg daily |
Glyburide: dosing adjustments | GFR < 60 use not recommended, no adjustments in hepatic impairment |
Glyburide: class | sulfonylurea |
Glyburide: MOA | Stimulates insulin release from the pancreatic beta cells; reduces glucose output from the liver; insulin sensitivity is increased at peripheral target sites |
Glyburide: AEs (3) | nausea, heartburn, hypoglycemia |
Created by:
kornblum
Popular Medical sets